Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice
Shinri Sato(Keio University), Yoko Ozawa(St. Luke's International Hospital), Sakiko Minami(Keio University Hospital), Chigusa Iyama, Mamoru Kamoshita(Keio University), Yohei Tomita(Keio University), Misa Suzuki(Minamiaoyama Eye Clinic), Kenya Yuki(Keio University), Atsuro Uchida(Keio University), Toshihide Kurihara(Keio University Hospital), Kazuo Tsubota(Keio University), Norihiro Nagai(Keio University), Hajime Shinoda(Keio University)
Cited by 25
Related Papers
Neurons Limit Angiogenesis by Titrating VEGF in Retina
|Cell|2014|321
New Grading System for the Evaluation of Chronic Ocular Manifestations in Patients with Stevens–Johnson Syndrome
|Ophthalmology|2007|311
Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes
|Diabetologia|2010|289
Functional lacrimal gland regeneration by transplantation of a bioengineered organ germ
|Nature Communications|2013|261